Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial

Gaudet, D, Méthot, J, Déry, S, Brisson, D, Essiembre, C, Tremblay, G, Tremblay, K, de Wal, J +4 more·2013·Gene Therapy
DOI 10.1038/gt.2012.43

Cited by (404)

Items 101–200 of 404

  1. Next-generation muscle-directed gene therapy by in silico vector design
    Shilpita Sarcar, Warut Tulalamba, Melvin Y. Rincón, Jaitip Tipanee, H. Q. Pham, Hanneke Evens, Dimitri Boon, Ermira Samara-Kuko, Marleen Keyaerts, Mariana Loperfido et al. · 2019 · Nature Communications
  2. Mechanism of action of anti-hypercholesterolemia drugs and their resistance
    Vishvanath Tiwari, Manoj Khokhar · 2014 · European Journal of Pharmacology
  3. The Role of Recombinant AAV in Precise Genome Editing
    Swati Bijlani, Ka Ming Pang, Venkatesh Sivanandam, Amanpreet Singh, Saswati Chatterjee · 2022 · Frontiers in Genome Editing
  4. Nanobiomaterial vectors for improving gene editing and gene therapy
    Shao Wei Hu, Tao Ding, Honghai Tang, Huiping Guo, Wenguo Cui, Yilai Shu · 2023 · Materials Today
  5. A versatile toolkit for overcoming AAV immunity
    Li, Xuefeng, Wei, Xiaoli, Lin, Jinduan, Ou, Li · 2022 · Frontiers in Immunology
  6. Precision medicine, genomics and drug discovery: Table 1.
    Lon R. Cardon, Tim Harris · 2016 · Human Molecular Genetics
  7. From Mutation Identification to Therapy: Discovery and Origins of the First Approved Gene Therapy in the Western World
    John J.P. Kastelein, Colin J. Ross, Michael R. Hayden · 2013 · Human Gene Therapy
  8. Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge
    Welles, Hugh C., Jennewein, Madeleine F., Mason, Rosemarie D., Narpala, Sandeep, Wang, Lingshu, Cheng, Cheng, Zhang, Yi, Todd, John-Paul, Lifson, Jeffrey D., Balazs, Alejandro B. et al. · 2018 · PLOS Pathogens
  9. Humoral immune responses to <scp>AAV</scp> gene therapy in the ocular compartment
    Whitehead, Michael, Osborne, Andrew, Yu‐Wai‐Man, Patrick, Martin, Keith · 2021 · Biological Reviews
  10. Controlled release strategies for rAAV-mediated gene delivery
    Ana Rey‐Rico, Magali Cucchiarini · 2015 · Acta Biomaterialia
  11. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID
    Carles Roca, Sandra Motas, Sara Marcó, Albert Ribera, Víctor Sánchez, Xavier Sánchez, Joan Bertolin, Xavier León, Jennifer Pérez, Miguel Garcia et al. · 2017 · Human Molecular Genetics
  12. Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs
    Maria Luisa Jaén, Laia Vilà, Ivet Elias, Verónica Jiménez, Jordi Rodó, Luca Maggioni, Rafael Ruiz de Gopegui i Fernández, Miguel Garcia, SERGIO A. MUÑOZ, David Callejas et al. · 2017 · Molecular Therapy — Methods & Clinical Development
  13. Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia
    Ezim Ajufo, Marina Cuchel · 2016 · Current Atherosclerosis Reports
  14. Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates
    Caroline Le Guiner, Knut Stieger, Alice Toromanoff, Mickaël Guilbaud, Alexandra Mendes-Madeira, Marie Devaux, Lydie Guigand, Yan Chérel, Philippe Moullier, Fabienne Rolling et al. · 2014 · PLoS ONE
  15. Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond
    Paul N. Valdmanis, Mark A. Kay · 2017 · Human Gene Therapy
  16. Gene therapy and editing: Novel potential treatments for neuronal channelopathies
    Robert C. Wykes, Gabriele Lignani · 2017 · Neuropharmacology
  17. Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency
    Anthony S. Wierzbicki, Adie Viljoen · 2012 · Expert Opinion on Biological Therapy
  18. Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy
    Boris Gorovits, Mitra Azadeh, George Buchlis, Michele Fiscella, Travis Harrison, Mike Havert, Sylvia Janetzki, Vibha Jawa, Brian R. Long, Yolanda D. Mahnke et al. · 2023 · The AAPS Journal
  19. Engineering viral vectors for acoustically targeted gene delivery
    Hongyi Li, Manwal Harb, John E. Heath, James S. Trippett, Mikhail G. Shapiro, Jerzy O. Szablowski · 2024 · Nature Communications
  20. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome
    Rabia Chaudhry, Adie Viljoen, Anthony S. Wierzbicki · 2018 · Expert Review of Clinical Pharmacology
  21. Centronuclear myopathies under attack: A plethora of therapeutic targets
    Hichem Tasfaout, Belinda Simone Cowling, Jocelyn Laporte · 2018 · Journal of Neuromuscular Diseases
  22. Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models
    Efrat Kurtzwald-Josefson, Dor Yadin, Shiraz Haron‐Khun, Maayan Waldman, Dan J. Aravot, Asher Shainberg, Michael Eldar, Edith Hochhauser, Michael Arad · 2017 · Heart Rhythm
  23. Novel therapeutics in hypertriglyceridemia
    Gryn, Steven E., Hegele, Robert A. · 2015 · Current Opinion in Lipidology
  24. Current Diagnosis and Management of Primary Chylomicronemia
    Hiroaki Okazaki, Takanari Gotoda, Masatsune Ogura, Shun Ishibashi, Kyoko Inagaki, Hiroyuki Daida, Toshio Hayashi, Mika Hori, Daisaku Masuda, Kota Matsuki et al. · 2021 · Journal of Atherosclerosis and Thrombosis
  25. Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
    Dwaipayan Sen, Balaji Balakrishnan, Nishanth Gabriel, Prachi P. Agrawal, Vaani Roshini, Rekha Samuel, Alok Srivastava, Giridhara Rao Jayandharan · 2013 · Scientific Reports
  26. The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System
    Françoise Piguet, Timothée De Saint-Denis, Emilie Audouard, Kévin Beccaria, Arthur André, Guillaume Wurtz, Raphael Schatz, Sandro Alves, Caroline Sevin, Michel Zérah et al. · 2020 · Human Gene Therapy
  27. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1
    Ahmad, Zahid, Wilson, Don P. · 2014 · Journal of clinical lipidology
  28. Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future
    Clara van Karnebeek, Kristin Bowden, Elizabeth Berry‐Kravis · 2016 · Pediatric Neurology
  29. Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy
    Daniel Gaudet, Jean‐Philippe Drouin‐Chartier, Patrick Couture · 2017 · Canadian Journal of Cardiology
  30. Regulatory and Exhausted T Cell Responses to AAV Capsid
    Gwladys Gernoux, James M. Wilson, Christian Mueller · 2017 · Human Gene Therapy
  31. Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia
    Piero Pingitore, Saverio Massimo Lepore, Carlo Pirazzi, Rosellina Margherita Mancina, Benedetta Maria Motta, Luca V. C. Valenti, Knut Erik Berge, Kjetil Retterstøl, Trond P. Leren, Olov Wiklund et al. · 2016 · Journal of clinical lipidology
  32. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
    Alberico Luigi Catapano, Ian M Graham, Guy De Backer, Olov Wiklund, M. John Chapman, Heinz Drexel, Arno Wilhelmus Hoes, Catriona Sian Jennings, Ulf Landmesser, Terje Rolf Pedersen et al. · 2016 · Kardiologia Polska
  33. Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver
    Wei Huang, Xianglan Liu, Nicholas J. Queen, Lei Cao · 2017 · Molecular Therapy — Methods & Clinical Development
  34. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia
    Ioanna Gouni‐Berthold · 2017 · Atherosclerosis Supplements
  35. Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
    Philip C. Buttery, Roger A. Barker · 2020 · Neurotherapeutics
  36. Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future
    Cleila Guimarães Pimenta Bosio, Vitória Loureiro Bettiol, Thuany Alencar‐Silva, Octávio Luiz Franco, Robert Edward Pogue, Juliana Lott Carvalho, Maria Sueli Soares Felipe · 2021 · Clinical Therapeutics
  37. The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
    Artyom Kachanov, Anastasiya Kostyusheva, Sergey Brezgin, Ivan Karandashov, N. I. Ponomareva, Andrey Tikhonov, Alexander N. Lukashev, Vadim S. Pokrovsky, Andrey A. Zamyatnin, Alessandro Parodi et al. · 2024 · Medicinal Research Reviews
  38. Safety and efficacy of therapies for chylomicronemia
    Isabel Shamsudeen, Robert Alexander Hegele · 2022 · Expert Review of Clinical Pharmacology
  39. A potassium leak channel silences hyperactive neurons and ameliorates status epilepticus
    Deblina Dey, Veit‐Simon Eckle, Iuliia Vitko, Kyle A. Sullivan, Zofia Maria Lasiecka, Bettina Winckler, Ruth L. Stornetta, John M. Williamson, Jaideep Kapur, Edward Perez‐Reyes · 2013 · Epilepsia
  40. rAAV-Mediated Tumorigenesis: Still Unresolved After an AAV Assault
    Paul N. Valdmanis, Leszek Lisowski, Mark A. Kay · 2012 · Molecular Therapy
  41. The 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide
    Qing Xie, John M. Spear, Alex J. Noble, Duncan R. Sousa, Nancy Meyer, Omar Davulcu, Fuming Zhang, Robert J. Linhardt, Scott M. Stagg, Michael Stewart Chapman · 2017 · Molecular Therapy — Methods & Clinical Development
  42. The ice age – A review on formulation of Adeno-associated virus therapeutics
    Philip Grossen, Irini Skaripa-Koukelli, Joost van Haasteren, Alexandra H.E. Machado, Christoph Dürr · 2023 · European Journal of Pharmaceutics and Biopharmaceutics
  43. Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies
    Fred David Ledley, Laura M. McNamee, V Uzdil, Irwin Morgan · 2013 · Gene Therapy
  44. Liver‐targeted gene therapy: Approaches and challenges
    Rajagopal N. Aravalli, John D. Belcher, Clifford J. Steer · 2015 · Liver Transplantation
  45. Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors
    Gabriella Dias Florencio Leite, Guillaume Précigout, Cyriaque Beley, Pierre-Olivier Buclez, Luis Garcı́a, Rachid Benchaouir · 2015 · Molecular Therapy — Methods & Clinical Development
  46. Efficient Production of Dual Recombinant Adeno-Associated Viral Vectors for Factor VIII Delivery
    Wang Qizhao, Biao Dong, Jenni Firrman, Sean Roberts, Andrea Rossi Moore, Wenjing Cao, Yong Diao, Philipp Kapranov, Ruian Xu, Weidong Xiao · 2014 · Human Gene Therapy Methods
  47. Gene therapy for hemophilia
    Steven W. Pipe · 2017 · Pediatric Blood & Cancer
  48. Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions
    Ursula Kassner, Tim Hollstein, Thomas Grenkowitz, Marion Wühle-Demuth, Bastian Salewsky, Ilja Demuth, Michaela Dippel, Elisabeth Steinhagen‐Thiessen · 2018 · Human Gene Therapy
  49. Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
    György Paragh, Ákos Németh, Mariann Harangi, Maciej Banach, Péter Fülöp · 2022 · Lipids in Health and Disease
  50. Current status of gene therapy for α-1 antitrypsin deficiency
    Heather S. Loring, Terence R. Flotte · 2014 · Expert Opinion on Biological Therapy
  51. Obstacles and future of gene therapy for hemophilia
    Arruda, Valder R, Samelson-Jones, Ben J · 2015 · Expert Opinion on Orphan Drugs
  52. New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments
    Seema Abbasi, Adnan Ahmed Khan, Muhammad W. Choudhry · 2024 · Cureus
  53. Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan.
    Celine-Lea Halioua-Haubold, James G. Peyer, James Smith, Zeeshaan Arshad, Matthew Scholz, David A. Brindley, Robert Edward MacLaren · 2017 · PubMed Central
  54. The Unusual Properties of the AAV Inverted Terminal Repeat
    Kenneth I. Berns · 2020 · Human Gene Therapy
  55. Synthetic Biology—Toward Therapeutic Solutions
    Viktor Haellman, Martin Fussenegger · 2015 · Journal of Molecular Biology
  56. Emerging therapies and therapeutic concepts for lysosomal storage diseases
    Thomas Kirkegaard · 2013 · Expert Opinion on Orphan Drugs
  57. A missense variant in CST3 exerts a recessive effect on susceptibility to age-related macular degeneration resembling its association with Alzheimer’s disease
    Joe M. Butler, Umar Sharif, Manir Ali, Martin McKibbin, Joseph P. Thompson, Richard Peter Gale, Yit Chiun Yang, Chris F. Inglehearn, Luminita Paraoan · 2015 · Human Genetics
  58. Viral Vector-Mediated Antisense Therapy for Genetic Diseases
    Marine Imbert, Gabriella Dias-Florencio, Aurélie Goyenvalle · 2017 · Genes
  59. Disorders of Lipid Metabolism
    Clay F. Semenkovich, Anne Carol Goldberg, Ira J. Goldberg · 2011 · Elsevier eBooks
  60. Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
    Erin D. Michos, Bishnu Hari Subedi, Parag H. Joshi, Steven Richard Jones, Seth Shay Martin, Michael Joseph Blaha · 2014 · Vascular Health and Risk Management
  61. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo
    Ling Yin, Geoffrey D. Keeler, Yuanhui Zhang, Brad E. Hoffman, Chen Ling, Keyun Qing, Arun Srivastava · 2020 · Gene Therapy
  62. The burden of familial chylomicronemia syndrome in Canadian patients
    Daniel Gaudet, Michael T. Stevenson, Nelly Komari, Grace A. Trentin, Caroline Crowson, Nandini Hadker, Sophie Bernard · 2020 · Lipids in Health and Disease
  63. Opportunities and challenges for applying model‐informed drug development approaches to gene therapies
    Artur A. Belov, Kimberly L. W. Schultz, Richard A. Forshee, Million A. Tegenge · 2021 · CPT Pharmacometrics & Systems Pharmacology
  64. Cell-penetrating peptides enhance the transduction of adeno-associated virus serotype 9 in the central nervous system
    Yuan Meng, Dong Sun, Yiyan Qin, Xiaoyi Dong, Guangzuo Luo, Ying Liu · 2021 · Molecular Therapy — Methods & Clinical Development
  65. Development of a Novel Recombinant Adeno-Associated Virus Production System Using Human Bocavirus 1 Helper Genes
    Zekun Wang, Fang Cheng, John F. Engelhardt, Ziying Yan, Jianming Qiu · 2018 · Molecular Therapy — Methods & Clinical Development
  66. Genetic burden linked to founder effects in Saguenay–Lac-Saint-Jean illustrates the importance of genetic screening test availability
    Mbarka Bchetnia, Luigi Bouchard, Jean Mathieu, Philippe M. Campeau, Charles Morin, Diane Brisson, Anne‐Marie Laberge, Hélène Vézina, Daniel Gaudet, Catherine Laprise · 2021 · Journal of Medical Genetics
  67. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat
    Piers R. Blackett, Jeanie B. Tryggestad, Sowmya Krishnan, Shibo Li, Weihong Xu, Petar Alaupovic, Carmen Quiroga, Kenneth C. Copeland · 2012 · Journal of clinical lipidology
  68. Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer
    Aurélie Moreau, Céline Vandamme, Mercedes Segovia, Marie Devaux, Mickaël Guilbaud, Gaëlle Tilly, Nicolas Jaulin, Johanne Le Duff, Yan Chérel, Jack‐Yves Deschamps et al. · 2014 · Molecular Therapy — Methods & Clinical Development
  69. How Will Genetics Inform the Clinical Care of Atrial Fibrillation?
    Shoemaker, M. Benjamin, Shah, Rajan L., Roden, Dan M., Perez, Marco V. · 2020 · Circulation Research
  70. Increasing the Clinical Potential and Applications of Anti-HIV Antibodies
    Casey K. Hua, Margaret E. Ackerman · 2017 · Frontiers in Immunology
  71. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects
    Piter J. Bosma, Marius Wits, Ronald P.J. Oude Elferink · 2020 · International Journal of Molecular Sciences
  72. Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system
    Pierre-Olivier Buclez, Gabriella Dias Florencio Leite, Karima Relizani, Cyriaque Beley, Luis Garcı́a, Rachid Benchaouir · 2016 · Molecular Therapy — Methods & Clinical Development
  73. Chylomicronemia Syndrome
    Anthony S. Wierzbicki · 2018 · Wiley eBooks
  74. Intrinsic Transgene Immunogenicity Gears CD8+ T-cell Priming After rAAV-Mediated Muscle Gene Transfer
    Maxime Carpentier, Stéphanie Lorain, Pascal Chappert, Mélanie Lalfer, Romain Hardet, Dominique Urbain, Cécile Peccate, Sahil Adriouch, Luis Garcı́a, Jean M. Davoust et al. · 2014 · Molecular Therapy
  75. AAV Production Using Baculovirus Expression Vector System
    Sandro, Quentin, Relizani, Karima, Benchaouir, Rachid · 2019 · Methods in Molecular Biology
  76. Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy
    Purdy, Ryan, John, Molly, Bray, Alissa, Clare, Alison J., Copland, David A., Chan, Ying Kai, Henderson, Robert H., Nerinckx, Fanny, Leroy, Bart P., Yang, Paul et al. · 2025 · Progress in Retinal and Eye Research
  77. Inhibition of ApoCIII
    Sophie J. Bernelot Moens, Julian C. van Capelleveen, Erik S.G. Stroes · 2014 · Current Opinion in Lipidology
  78. Gene therapy for the neurological manifestations in lysosomal storage disorders
    Seng H. Cheng · 2014 · Journal of Lipid Research
  79. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing
    Jia Liu, Sailan Shui · 2016 · Journal of Controlled Release
  80. Current AAV-mediated gene therapy in sensorineural hearing loss
    Jieyu Qi, Xiaolong Fu, Liyan Zhang, Fangzhi Tan, Nianci Li, Qiuhan Sun, Xiaojie Hu, Zuhong He, Ming Xia, Renjie Chai · 2022 · Fundamental Research
  81. Origin and therapy for hypertriglyceridaemia in type 2 diabetes
    Jing Pang, Dick C. Chan, Gerald Francis Watts · 2014 · World Journal of Diabetes
  82. Treatment of primary hypertriglyceridemia states – General approach and the role of extracorporeal methods
    Claudia Stefanutti, Ulrich Julius · 2015 · Atherosclerosis Supplements
  83. Orlistat Therapy for Children With Type 1 Hyperlipoproteinemia: A Randomized Clinical Trial
    Nivedita Patni, Claudia Quittner, Abhimanyu Garg · 2018 · The Journal of Clinical Endocrinology & Metabolism
  84. Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors
    Adrian Westhaus, Marti Cabanes‐Creus, Kimberley L. Dilworth, Erhua Zhu, David Salas Gómez, Renina Gale Navarro, Anais K. Amaya, Suzanne Scott, Magdalena Kwiatek, Alexandra L. McCorkindale et al. · 2023 · Human Gene Therapy
  85. The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency
    Elisabeth Steinhagen‐Thiessen, Erik S.G. Stroes, Handrean Soran, Colin Johnson, Philippe Moulin, Giorgio Iotti, Marco Zibellini, Bas Ossenkoppele, Michaela Dippel, Maurizio Rocco Averna · 2016 · Atherosclerosis
  86. Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies
    Uma Kavita, Yan‐Shan Dai, Lisa Salvador, Wendy Miller, Leonard P. Adam, Paul Lévesque, Yan J Zhang, Qin Ji, Renuka C. Pillutla · 2018 · Human Gene Therapy Methods
  87. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases
    Kenneth I. Berns, Arun Srivastava · 2019 · Gastroenterology Clinics of North America
  88. PCR-based detection of gene transfer vectors: application to gene doping surveillance
    Irene C. Perez, Caroline Le Guiner, Weiyi Ni, Jennifer K Lyles, Philippe Moullier, Richard O. Snyder · 2013 · Analytical and Bioanalytical Chemistry
  89. Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitability
    Albert Snowball, Stéphanie Schorge · 2015 · FEBS Letters
  90. Gene editing technology as an approach to the treatment of liver diseases
    Rajagopal N. Aravalli, Clifford J. Steer · 2016 · Expert Opinion on Biological Therapy
  91. Identification of candidate protective variants for common diseases and evaluation of their protective potential
    Joe M. Butler, Neil Hall, Niro Narendran, Yit Chiun Yang, Luminita Paraoan · 2017 · BMC Genomics
  92. Preclinical Toxicity Evaluation of AAV for Pain: Evidence from Human AAV Studies and from the Pharmacology of Analgesic Drugs
    Pleticha, Josef, Heilmann, Lukas F, Evans, Christopher H, Asokan, Aravind, Samulski, Richard Jude, Beutler, Andreas S · 2014 · Molecular Pain
  93. Hypertriglyceridemia and acute pancreatitis: clinical and basic research—a narrative review
    Lin Gao, Weiqin Li · 2023 · Journal of Pancreatology
  94. New trends in articular cartilage repair
    Magali Cucchiarini, Christel Henrionnet, Didier Mainard, Astrid Pinzano, Henning Madry · 2015 · Journal of Experimental Orthopaedics
  95. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses
    Chen Ling, Baozheng Li, Wenqin Ma, Arun Srivastava · 2016 · Human Gene Therapy Methods
  96. Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back
    Laurine Buscara, David‐Alexandre Gross, Nathalie Danièle · 2020 · Journal of Personalized Medicine
  97. Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
    Sebastian P. Fuchs, José M. Martinez-Navío, Guangping Gao, Ronald C. Desrosiers · 2016 · PLoS ONE
  98. Allometric-like scaling of AAV gene therapy for systemic protein delivery
    Alexandra Burr, Patrick Erickson, Raphaela Bento, Kariman A. Shama, Charles M. Roth, Biju Parekkadan · 2022 · Molecular Therapy — Methods & Clinical Development
  99. Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector
    Romain Hardet, Benjamin Chevalier, Léa Dupaty, Yassine Naïmi, Gaëtan Riou, Laurent Drouot, Laetitia Jean, Anna Salvetti, Olivier Boyer, Sahil Adriouch · 2015 · Molecular Therapy
  100. Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
    Emily Xia, Rongqi Cathleen Duan, Fushan Shi, Kyle E. Seigel, Hartmut Grasemann, Jim Hu · 2018 · Molecular Therapy — Nucleic Acids